JP2007530698A5 - - Google Patents

Download PDF

Info

Publication number
JP2007530698A5
JP2007530698A5 JP2007506412A JP2007506412A JP2007530698A5 JP 2007530698 A5 JP2007530698 A5 JP 2007530698A5 JP 2007506412 A JP2007506412 A JP 2007506412A JP 2007506412 A JP2007506412 A JP 2007506412A JP 2007530698 A5 JP2007530698 A5 JP 2007530698A5
Authority
JP
Japan
Prior art keywords
pyrrolidin
ylmethyl
methanone
biphenyl
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007506412A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007530698A (ja
JP4777974B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/010240 external-priority patent/WO2005097740A1/en
Publication of JP2007530698A publication Critical patent/JP2007530698A/ja
Publication of JP2007530698A5 publication Critical patent/JP2007530698A5/ja
Application granted granted Critical
Publication of JP4777974B2 publication Critical patent/JP4777974B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007506412A 2004-04-01 2005-03-25 ヒスタミンh3受容体作用物質、製剤および治療的使用 Expired - Fee Related JP4777974B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US55854204P 2004-04-01 2004-04-01
US60/558,542 2004-04-01
US61710104P 2004-10-08 2004-10-08
US60/617,101 2004-10-08
PCT/US2005/010240 WO2005097740A1 (en) 2004-04-01 2005-03-25 Histamine h3 receptor agents, preparation and therapeutic uses

Publications (3)

Publication Number Publication Date
JP2007530698A JP2007530698A (ja) 2007-11-01
JP2007530698A5 true JP2007530698A5 (enExample) 2008-05-15
JP4777974B2 JP4777974B2 (ja) 2011-09-21

Family

ID=34964070

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007506412A Expired - Fee Related JP4777974B2 (ja) 2004-04-01 2005-03-25 ヒスタミンh3受容体作用物質、製剤および治療的使用

Country Status (17)

Country Link
US (1) US7632857B2 (enExample)
EP (1) EP1735278B1 (enExample)
JP (1) JP4777974B2 (enExample)
CN (1) CN1960969B (enExample)
AT (1) ATE454372T1 (enExample)
AU (1) AU2005230881B9 (enExample)
BR (1) BRPI0509298A (enExample)
CA (1) CA2561628C (enExample)
CY (1) CY1109860T1 (enExample)
DE (1) DE602005018758D1 (enExample)
DK (1) DK1735278T3 (enExample)
ES (1) ES2337376T3 (enExample)
MX (1) MXPA06011167A (enExample)
PL (1) PL1735278T3 (enExample)
PT (1) PT1735278E (enExample)
SI (1) SI1735278T1 (enExample)
WO (1) WO2005097740A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008301B2 (en) * 2004-04-01 2011-08-30 Eli Lilly And Company Histamine H3 receptor agents, preparation and therapeutic uses
EP1784400B1 (en) * 2004-08-23 2015-01-14 Eli Lilly And Company Histamine h3 receptor agents, preparation and therapeutic uses
GT200600042A (es) * 2005-02-10 2006-09-27 Aventis Pharma Inc Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a
CN101151244B (zh) * 2005-04-01 2014-09-03 伊莱利利公司 组胺h3受体活性剂、制备和治疗用途
JP5193033B2 (ja) * 2005-07-01 2013-05-08 イーライ リリー アンド カンパニー ヒスタミンh3受容体薬剤、製剤及び治療的使用
US8158673B2 (en) * 2005-10-27 2012-04-17 Pfizer Inc. Histamine-3 receptor antagonists
WO2007055418A1 (ja) * 2005-11-10 2007-05-18 Banyu Pharmaceutical Co., Ltd. アザ置換スピロ誘導体
ATE485294T1 (de) 2005-11-18 2010-11-15 Hoffmann La Roche Azaindol-2-carboxamid-derivate
US7351708B2 (en) 2005-12-16 2008-04-01 Hoffmann-La Roche Inc. Pyrrolo [2,3-b] pyridine derivatives
AU2007227681A1 (en) * 2006-03-15 2007-09-27 Wyeth N-substituted-azacyclylamines as histamine-3 antagonists
WO2008005338A1 (en) * 2006-06-29 2008-01-10 Arena Pharmaceuticals, Inc. Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
TW200823204A (en) * 2006-10-17 2008-06-01 Arena Pharm Inc Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine H3-receptor useful for the treatment of disorders related thereto
JP2010529130A (ja) * 2007-06-08 2010-08-26 アリーナ ファーマシューティカルズ, インコーポレイテッド (r)−1−{2−[4’−(3−メトキシ−プロパン−1−スルホニル)−ビフェニル−4−イル]−エチル}−2−メチル−ピロリジンの結晶形、およびその組成物ならびにそれに関連する方法
CA2700691A1 (en) * 2007-10-01 2009-04-09 F. Hoffmann-La Roche Ag New biaryl derivatives
ES2479440T3 (es) * 2008-01-30 2014-07-24 Cephalon, Inc. Derivados de piridazina sustituidos que tienen actividad antagonista de histamina H3
JP5805792B2 (ja) * 2011-02-23 2015-11-10 スヴェン・ライフ・サイエンシズ・リミテッド ヒスタミンh3レセプターリガンドとしての新規な化合物
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
MD20140130A2 (ro) 2012-06-29 2015-04-30 Pfizer Inc. 4-(amino-substituite)-7H-pirolo[2,3-d]pirimidine noi ca inhibitori de LRRK2
CN112521369A (zh) 2013-03-13 2021-03-19 福马治疗股份有限公司 用于抑制fasn的化合物及组合物
WO2015092592A1 (en) 2013-12-17 2015-06-25 Pfizer Inc. Novel 3,4-disubstituted-1h-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7h-pyrrolo[2,3-c]pyridazines as lrrk2 inhibitors
JP6633618B2 (ja) * 2014-08-21 2020-01-22 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company 強力なrock阻害剤としてのタイドバックのベンズアミド誘導体
MY189453A (en) 2015-06-03 2022-02-14 Bristol Myers Squibb Co 4-hydroxy-3-(heteroaryl)pyridine-2-one apj agonists for use in the treatment of cardiovascular disorders
RS62639B1 (sr) 2015-07-06 2021-12-31 Alkermes Inc Hetero-halo inhibitori histonskih deacetilaza
EP3319968A1 (en) 2015-07-06 2018-05-16 Rodin Therapeutics, Inc. Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
RU2722149C1 (ru) 2015-09-14 2020-05-27 Пфайзер Инк. Новые производные имидазо[4,5-c] хинолинов и имидазо[4,5-c][1,5] нафтиридинов в качестве ингибиторов LRRK2
JP6756925B2 (ja) 2017-01-11 2020-09-16 ロダン・セラピューティクス,インコーポレーテッド ヒストンデアセチラーゼの二環式阻害剤
ES2914355T3 (es) 2017-08-07 2022-06-09 Alkermes Inc Inhibidores bicíclicos de la histona desacetilasa
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
WO2020092395A1 (en) 2018-10-29 2020-05-07 Forma Therapeutics, Inc. SOLID FORMS OF (4-(2-FLUORO-4-(1-METHYL-1 H-BENZO[d]IMIDAZOL-5-YL)BENZOYL) PIPERAZIN-1-YL)(1-HYDROXYCYCLOPROPYL)METHANONE
US20230257357A1 (en) * 2020-06-29 2023-08-17 Bacainn Biotherapeutics, Ltd. Probenecid compounds for the treatment of inflammasome-mediated lung disease

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2579596B1 (fr) 1985-03-26 1987-11-20 Inst Nat Sante Rech Med (imidazolyl-4) piperidines, leur preparation et leur application en therapeutique
FR2671083B1 (fr) 1990-12-31 1994-12-23 Inst Nat Sante Rech Med Nouvelles 4-(4-imidazolyl) piperidines substituees en 1, leur preparation ainsi que leurs applications therapeutiques.
US5652258A (en) 1995-05-30 1997-07-29 Gliatech, Inc. 2-(4-imidazoyl) cyclopropyl derivatives
CA2222099A1 (en) 1995-05-30 1996-12-05 Gliatech, Inc. 1h-4(5)-substituted imidazole derivatives
PL328369A1 (en) 1996-02-09 1999-01-18 Black James Foundation Ligands of histamin h receptor
US6620839B2 (en) * 2000-07-13 2003-09-16 Abbott Laboratories 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
AU2002254114A1 (en) 2001-03-23 2002-10-08 Eli Lilly And Company Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
PL371435A1 (en) * 2002-02-01 2005-06-13 Novo Nordisk A/S Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
AU2004215428B2 (en) * 2003-02-26 2009-08-27 Sugen LLC Aminoheteroaryl compounds as protein kinase inhibitors
EP1720861A2 (en) 2004-02-25 2006-11-15 Eli Lilly And Company Histamine h3 receptor antagonists, preparation and therapeutic uses

Similar Documents

Publication Publication Date Title
JP2007530698A5 (enExample)
CA2561628A1 (en) Histamine h3 receptor agents, preparation and therapeutic uses
JP2009535356A5 (enExample)
JP2011500659A5 (enExample)
JP2012533546A5 (enExample)
JP2009534470A5 (enExample)
JP2020527175A5 (enExample)
JP2008525417A5 (enExample)
JP2011515412A5 (enExample)
JP2010538076A5 (enExample)
JP2008526724A5 (enExample)
JP2011519854A5 (enExample)
JP2004506632A5 (enExample)
JP2009531376A5 (enExample)
JP2014511869A5 (enExample)
JP2009535362A5 (enExample)
JP2009544675A5 (enExample)
HRP20120202T1 (hr) AMIDOFENOKSIINDAZOLI, KORISNI KAO INHIBITORI c-MET
CU23713B7 (es) Cristales anhidros que incluyen una sal del ácido málico de una 2-indolinona sustituida con 3-pirrol, métodos de preparación y composiciones que las contienen
RU2009125019A (ru) Производные карбоновой кислоты
RU2014103587A (ru) Производные циклических аминов в качестве антагонистов рецептора ер4
HRP20170638T1 (hr) MODULATORI RETINOIDNIMA SRODNOG SIROČETA RECEPTORA γ (ROR-γ), NAMIJENJENI UPOTREBI U LIJEČENJU AUTOIMUNIH I PROTUUPALNIH BOLESTI
RU2009115963A (ru) Производные оксадиазола, обладающие противовоспалительными и иммунодепрессантными свойствами
PE20090606A1 (es) Nuevos inhibidores de catepsina c y uso
JP2012530765A5 (enExample)